An Interview with Reason of Repair Biotechnologies on Reversal of Atherosclerosis – Fight Aging!

Repair Biotechnologies, co-founded by the author and Bill Cherman, is currently developing a gene therapy approach that has shown promising results in rapidly reversing atherosclerosis in mice. Atherosclerosis is a major cause of mortality, leading to heart attacks and strokes. The company’s Cholesterol Degrading Platform (CDP) has demonstrated significant reversal of metabolic dysfunction-associated steatohepatitis, atherosclerosis, and familial hypercholesterolemia in mouse models. Traditional treatments for these conditions have shown limited effectiveness in reversing established damage, while CDP therapy has delivered impressive results in improving blood chemistry and reducing disease progression. In comparison to existing treatments, CDP therapy has outperformed in reversing fibrosis and stabilizing plaques. The results suggest that targeting excess free cholesterol could be a key strategy in treating various age-related and obesity-related conditions. For more information, visit the Link: https://www.lifespan.io/news/new-gene-therapy-reverses-atherosclerosis-in-mice/.